Added to YB: 2026-08-10
Pitch date: 2026-08-06
FRE.DE [neutral]
Fresenius SE & Co. KGaA
+0.06%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
Market Cap
EUR 26.3B
Pitch Price
EUR 47.03
Price Target
N/A
Dividend
2.25%
EV/EBITDA
10.97
P/E
16.82
EV/Sales
1.59
Sector
Health Care Providers and Services
Category
growth
Fresenius (FRE Germany): Kabi and Helios deliver
FRE.DE (earnings): Q3 organic sales +6%, adj EBIT +11%, core EPS beat; FY core EPS guidance raised to 10-15% growth. Kabi driven by Biopharma/Nutrition/MedTech offsetting weak US IV pricing; Helios Germany back to healthy organic growth. Portfolio mix shift to higher-margin biz playing out.
Read full article (2 min)